Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Operating Leases: 2022-2025

Historic Operating Leases for Biofrontera (BFRI) over the last 3 years, with Sep 2025 value amounting to $136,000.

  • Biofrontera's Operating Leases fell 58.02% to $136,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $136,000, marking a year-over-year decrease of 58.02%. This contributed to the annual value of $276,000 for FY2024, which is 65.67% down from last year.
  • As of Q3 2025, Biofrontera's Operating Leases stood at $136,000, which was down 39.01% from $223,000 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Operating Leases peaked at $848,000 during Q4 2022, and registered a low of $136,000 during Q3 2025.
  • Its 3-year average for Operating Leases is $433,400, with a median of $383,500 in 2024.
  • Data for Biofrontera's Operating Leases shows a maximum YoY plummeted of 65.67% (in 2024) over the last 5 years.
  • Quarterly analysis of 4 years shows Biofrontera's Operating Leases stood at $848,000 in 2022, then decreased by 5.19% to $804,000 in 2023, then tumbled by 65.67% to $276,000 in 2024, then tumbled by 58.02% to $136,000 in 2025.
  • Its Operating Leases stands at $136,000 for Q3 2025, versus $223,000 for Q2 2025 and $220,000 for Q1 2025.